These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 35175284
1. Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial. Sadigh G, Gray RJ, Sparano JA, Yanez B, Garcia SF, Timsina LR, Obeng-Gyasi S, Gareen I, Sledge GW, Whelan TJ, Cella D, Wagner LI, Carlos RC. JAMA Oncol; 2022 Apr 01; 8(4):579-586. PubMed ID: 35175284 [Abstract] [Full Text] [Related]
2. Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial. Sadigh G, Gray RJ, Sparano JA, Yanez B, Garcia SF, Timsina LR, Sledge GW, Cella D, Wagner LI, Carlos RC. Cancer; 2021 Jul 15; 127(14):2545-2552. PubMed ID: 33793979 [Abstract] [Full Text] [Related]
6. Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy: A Post Hoc Analysis of a Randomized Clinical Trial. Yanez B, Gray RJ, Sparano JA, Carlos RC, Sadigh G, Garcia SF, Gareen IF, Whelan TJ, Sledge GW, Cella D, Wagner LI. JAMA Oncol; 2021 Jun 17; 7(8):1-7. PubMed ID: 34137783 [Abstract] [Full Text] [Related]
7. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial. Albain KS, Gray RJ, Makower DF, Faghih A, Hayes DF, Geyer CE, Dees EC, Goetz MP, Olson JA, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Wood WC, Keane MM, Gomez HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW, Sparano JA. J Natl Cancer Inst; 2021 Apr 06; 113(4):390-399. PubMed ID: 32986828 [Abstract] [Full Text] [Related]
13. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers. Cheng E, Soulos PR, Irwin ML, Cespedes Feliciano EM, Presley CJ, Fuchs CS, Meyerhardt JA, Gross CP. JAMA Netw Open; 2021 Dec 01; 4(12):e2139593. PubMed ID: 34919133 [Abstract] [Full Text] [Related]
14. Associations between health insurance status, neighborhood deprivation, and treatment delays in women with breast cancer living in Georgia. Awan S, Saini G, Gogineni K, Luningham JM, Collin LJ, Bhattarai S, Aneja R, Williams CP. Cancer Med; 2023 Aug 01; 12(16):17331-17339. PubMed ID: 37439033 [Abstract] [Full Text] [Related]
17. Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival. Lipsyc-Sharf M, Ballman KV, Campbell JD, Muss HB, Perez EA, Shulman LN, Carey LA, Partridge AH, Warner ET. JAMA Netw Open; 2023 Oct 02; 6(10):e2339584. PubMed ID: 37878313 [Abstract] [Full Text] [Related]